Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Identify which cards provide flexible rewards without any fees. Compare your options for optimal rewards.
26,016 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Walmart stock fell today after management signaled a cautious outlook despite solid revenue growth. This article brea...
As Agora releases Q4 2025 data, investors will watch API growth, customer momentum, and profitability signals. This g...
Redwire Corporation stock popped today as investors weighed contract news, analyst commentary, and growth potential. ...
The AI stock story is shifting from last year’s heroes to new winners in 2026. This guide explains why the leadership...
When gas prices stay high, shoppers tighten belts and retailers with value-driven models often outperform. This artic...
UiPath edges higher as investors monitor its agentic automation strategy ahead of earnings. This analysis breaks down...
As Netflix faces slowing growth, the question on investors' minds is simple: could the streamer be about to buy somet...
A Monday surge put Archer Aviation stock in the spotlight as investors reacted to major eVTOL news. This guide breaks...
Narrowing the lens on rare earths reveals how policy shifts, EV demand, and new mines could shape USA Rare Earth's st...
A sharp rally in Chime Financial shares followed stronger-than-expected Q4 guidance. This piece breaks down the drive...
Salesforce stock just can't catch a break, even after a record quarter. This deep dive explains the forces at play, w...